QLI - qlsyy.net Company Cash on Hand

Brandmark of Qilian International Corp (QLI)

Legacy capacity constraints are weighing on the margins of Qilian International (QLI), yet cash flow dynamics on GURU.Markets demonstrate growth, where 0.11 serves as the current value of the indicator. The financial base relies on the production of veterinary antibiotics and licorice extracts. Meanwhile, the company synthesizes these preparations autonomously by purchasing plant components from farmers, which creates a dependency on external raw material suppliers.

QLI - Qilian International Holding Group Limited Company Liquid Assets over the range 07/04/2022 - 08/17/2024

Comprehensive metric breakdowns and analytics for Qilian International Holding (QLI)

Analysis of all company metrics:QLI Qilian International
Product sample of qlsyy.net

This indicator measures immediate liquidity, reflecting the volume of available funds for operational management and the settlement of liabilities. The dynamics of this metric determine financial stability by excluding market fluctuations in asset values. By analyzing the current cash balance, an investor sees the value of 0.11, which allows for an assessment of the margin of safety. Excess funds reduce profitability, while a deficit creates default risks. For Qilian International (QLI), such reserves are critical amid raw material price volatility in the chemical segment.

Direct competitors

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|Company Liquid Assets Pacira BioSciences (PCRX)|ARS Corp - Company Cash Volume|TBPH: Company Cash Funds|AQST: Company Cash Volume|SCPH - Company Liquid Assets|TECX (Tectonic) - Company Cash Volume|Company Cash Reserve Tonix Pharmaceuticals Holding Corp. TNXP|Company Cash Funds SXT Pharmaceuticals (SXTC)|Company Cash Volume Eupraxia Pharmaceuticals Inc. (EPRX)|Company Cash Funds BioHarvest Sciences BHST|EXOZ (Invizyne) - Company Total Cash Volume|ORMP: Company Cash on Hand|ENTX (Entera Bio Ltd) - Company Cash and Cash Equivalents|HYFT: Company Cash Volume|Company Cash on Hand ABVC BioPharma Inc.|CPIX (cumberlandpharma.com) - Company Cash Volume|Company Cash Funds QNTM|Company Cash Volume FGEN|Company Cash on Hand Telomir Pharmaceuticals TELO|Company Cash Volume RANI (ranitherapeutics.com)|SNYR (Synergy CHC Corporation) - Company Total Cash Volume|RLYB - Company Cash Funds|LEXX (Lexaria Bioscience Corp.) - Company Cash and Cash Equivalents|pulmatrix.com (PULM) - Company Cash Funds|PTHL (Pheton) - Company Cash Funds|Company Cash Funds Aptorum|Company Cash Reserve Lyra Therapeutics Inc. LYRA|Company Cash Volume IBO|TNFA (TNF Pharmaceuticals, Inc.) - Company Cash Balance|Company Cash Funds cbdMD, Inc. YCBD|Company Cash Balance PRFX|Altamira Therapeutics Ltd. - Company Cash Volume|Company Cash Reserve Lipella Pharmaceuticals Inc|OPTN: Company Cash Volume|Pieris - Company Cash Balance|Company Cash on Hand PROC|Company Cash Volume petrospharma.com|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance